173 related articles for article (PubMed ID: 28115829)
1. Ocular melanoma-when you have seen one, you have not seen them all: a clinical outcome study from the Surveillance, Epidemiology and End Results (SEER) database (1973-2012).
Mahendraraj K; Shrestha S; Lau CS; Chamberlain RS
Clin Ophthalmol; 2017; 11():153-160. PubMed ID: 28115829
[TBL] [Abstract][Full Text] [Related]
2. Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973-2012).
Mahendraraj K; Lau CS; Lee I; Chamberlain RS
Clin Ophthalmol; 2016; 10():2113-2119. PubMed ID: 27822007
[TBL] [Abstract][Full Text] [Related]
3. Uveal and conjunctival melanomas: disease course and outcomes in Chinese patients.
Chan JYY; Lam SC; Yuen HKL
Hong Kong Med J; 2023 Dec; 29(6):506-513. PubMed ID: 38044329
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis.
Bishop KD; Olszewski AJ
Int J Cancer; 2014 Jun; 134(12):2961-71. PubMed ID: 24272143
[TBL] [Abstract][Full Text] [Related]
5. Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines.
Refaian N; Schlereth SL; Koch KR; Notara M; Hos D; Mescher M; Iden S; Bosch JJ; Jager MJ; Cursiefen C; Heindl LM
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5691-7. PubMed ID: 26313304
[TBL] [Abstract][Full Text] [Related]
6. Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.
Jang BS; Chang JH; Oh S; Lim YJ; Kim IH
Strahlenther Onkol; 2017 Nov; 193(11):931-942. PubMed ID: 28879443
[TBL] [Abstract][Full Text] [Related]
7. Primary bilateral uveal melanoma: a population-based study and systematic review.
Scott JF; Vyas R; Galvin J; Gotow E; Fiessinger L; Gerstenblith AT; Gerstenblith MR
Clin Exp Ophthalmol; 2018 Jul; 46(5):502-510. PubMed ID: 29219254
[TBL] [Abstract][Full Text] [Related]
8. Mortality after uveal and conjunctival melanoma: which tumour is more deadly?
Kujala E; Tuomaala S; Eskelin S; Kivelä T
Acta Ophthalmol; 2009 Mar; 87(2):149-53. PubMed ID: 18937804
[TBL] [Abstract][Full Text] [Related]
9. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
Martorano LM; Winkelmann RR; Cebulla CM; Abdel-Rahman MH; Campbell SM
Int J Dermatol; 2014 Jun; 53(6):657-63. PubMed ID: 24697775
[TBL] [Abstract][Full Text] [Related]
10. So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020.
Rodrigues M; Koning L; Coupland SE; Jochemsen AG; Marais R; Stern MH; Valente A; Barnhill R; Cassoux N; Evans A; Galloway I; Jager MJ; Kapiteijn E; Romanowska-Dixon B; Ryll B; Roman-Roman S; Piperno-Neumann S;
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31336679
[TBL] [Abstract][Full Text] [Related]
11. Methylation-driven gene DLL3 is a potential prognostic biomarker in ocular melanoma correlating with metastasis.
Yang L; Wang G; Shi H; Jia S; Ruan J; Cui R; Ge S
Front Oncol; 2022; 12():964902. PubMed ID: 36338696
[TBL] [Abstract][Full Text] [Related]
12. Opposite Roles of BAP1 in Overall Survival of Uveal Melanoma and Cutaneous Melanoma.
Liu-Smith F; Lu Y
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32028647
[TBL] [Abstract][Full Text] [Related]
13. Uveal melanoma-associated cancers revisited.
Alfaar AS; Saad A; Elzouki S; Abdel-Rahman MH; Strauss O; Rehak M
ESMO Open; 2020 Nov; 5(6):e000990. PubMed ID: 33257317
[TBL] [Abstract][Full Text] [Related]
14. Non-ocular primary malignancies in patients with uveal melanoma: the Liverpool experience.
Heussen FM; Coupland SE; Kalirai H; Damato BE; Heimann H
Br J Ophthalmol; 2016 Mar; 100(3):356-9. PubMed ID: 26178903
[TBL] [Abstract][Full Text] [Related]
15. Incidence and mortality of uveal melanoma in Australia (1982-2014).
Beasley AB; Preen DB; McLenachan S; Gray ES; Chen FK
Br J Ophthalmol; 2023 Mar; 107(3):406-411. PubMed ID: 34880052
[TBL] [Abstract][Full Text] [Related]
16. Differences and Similarities in Epidemiology and Risk Factors for Cutaneous and Uveal Melanoma.
Brănișteanu DE; Porumb-Andrese E; Stărică A; Munteanu AC; Toader MP; Zemba M; Porumb V; Cozmin M; Moraru AD; Nicolescu AC; Brănișteanu DC
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241175
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and prognosis of patients with metastatic ocular and orbital melanoma: A bi-institutional study.
Liu X; Yue H; Jiang S; Kong L; Xu Y; Chen Y; Wang C; Wang Y; Zhu X; Kong Y; Zhang X; Qian J; Luo Z
Cancer Med; 2023 Aug; 12(15):16163-16172. PubMed ID: 37409486
[TBL] [Abstract][Full Text] [Related]
18. Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors.
Wu M; Yavuzyigitoglu S; Brosens E; Ramdas WD; Kiliç E;
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):45. PubMed ID: 37902747
[TBL] [Abstract][Full Text] [Related]
19. Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer.
Piperno-Neumann S; Piulats JM; Goebeler M; Galloway I; Lugowska I; Becker JC; Vihinen P; Van Calster J; Hadjistilianou T; Proença R; Caminal JM; Rogasik M; Blay JY; Kapiteijn E
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31200439
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to Immunotherapy.
Vilbert M; Koch EC; Rose AAN; Laister RC; Gray D; Sotov V; Penny S; Spreafico A; Pinto DM; Butler MO; Saibil SD
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
